For C.J. Hardin, an Army veteran, dealing with post-traumatic stress disorder is an everyday feat. After years of pills and therapy failed to help his disorder, Hardin knew he needed an alternative. So he turned to a surprising substitute that’s at the forefront of a revolution in neuroscience and medicine: psychedelics like MDMA and psilocybin. Science correspondent Miles O’Brien reports.

Watch the Segment here.

Hardin took MDMA, more commonly known as Ecstasy, under the watchful eyes of therapists Michael and Annie Mithoefer, a husband-and-wife team based in Charleston, South Carolina.

“I had three experiences at full dosage, but the effects after the first treatment were profound. I would have said a 60 percent reduction in my symptoms immediately. I felt a mighty change had occurred”